Found 11 matching trials
Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)
PHASE2This is a Phase 2, multicenter study in adult participants with an acute CO...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Lung Health Center
A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis
PHASE2This study will evaluate the efficacy, safety, pharmacokinetics and pharmac...
Location
Connect Investigative Site 310
A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD
PHASE2This study is a single-arm, open-label, multi-center clinical study designe...
Location
Connect Investigative Site 01
A Study to Evaluate CBP-201, Rademikibart, in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps
PHASE2This study will evaluate the effect of CBP-201, rademikibart, in adult pati...
Location
Connect Investigative Site 130
A Comparative Study of the Pharmacokinetics of SIM0718 Injection in Healthy Adult Subjects in China
PHASE1A study to compare the pharmacokinetics, safety and immunogenicity of SIM07...
Location
Jinan Central Hospital
Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation
PHASE2This study will evaluate the efficacy, safety of two dose levels of CBP-201...
Location
Connect Investigative Site 154
A Study to Evaluate the Pharmacokinetics Similarity of CBP-201 in Healthy Adult Chinese Subjects
PHASE1This is a single-center, randomized, open-label, single-dose, parallel-desi...
Location
The Second Hospital of Anhui Medical University
Rademikibart IV for Acute Asthma and COPD Exacerbation
PHASE2A Phase 2, open-label, single-arm trial to evaluate IV rademikibart as an a...
Location
Columbus Clinical Services, LLC
A Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in China
PHASE2This study will evaluate the efficacy and safety of CBP-201 in Chinese subj...
Location
Connect Investigative Site 33
CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitis
PHASE3This is a Phase 3, randomized, double-blinded, placebo-controlled trial in ...
Location
Multiple Locations